In this report, we aimed to assess the effect of G-CSF administration on the mobilization of VSELs, EPCs, and proangiogenic monocyte subsets in ALL patients with complete remission after chemotherapy. This evidence concerns the gene CSF3 and acute lymphoblastic leukemia.